Literature DB >> 16184834

Chlamydia pneumoniae, herpes simplex virus and cytomegalovirus in symptomatic and asymptomatic high-grade internal carotid artery stenosis. Does infection influence plaque stability?

B T Müller1, R Huber, B Henrich, O Adams, G Berns, M Siebler, S Jander, W Müller, R Loncar, E Godehardt, W Sandmann.   

Abstract

BACKGROUND: Current debates are focused on inflammatory processes in atherosclerotic lesions as a possible pathomechanism for destabilization and thrombembolism. In this prospective study the role of systemic and local infection in patients with high-grade internal carotid artery stenosis (ICA) was evaluated. PATIENTS AND METHODS: Serum antibody titers of 109 consecutive patients, who underwent surgery for ICA stenosis (asymptomatic n = 40, symptomatic n = 69) were prospectively measured for Chlamydia pneumoniae (Cpn) (IgA and IgG), Herpes simplex virus (HSV) (IgG, IgM) and Cytomegalovirus (CMV) (IgG, IgM) respectively. 53 carotis plaques of this group (asymptomatic n = 17, symptomatic n = 36) could be analyzed by polymerase chain reaction (PCR) for Cpn-, HSV- and CMV-DNA presence.
RESULTS: Seropositivity was found in 61,5% for Cpn, 91,7% for HSV and 72,5% CMV respectively. No significant relation was found between symptomatic and asymptomatic patients as well as no difference was seen for presence of IgA antibodies against Cpn comparing both groups. Plaque-PCR revealed Cpn in 7 cases (13,2%), HSV in 2 cases (3,8%) and no CMV had been detected. Again, no significant relationship was found concerning symptomatic and asymptomatic patients. All 9 PCR-positive plaques displayed lesions of "complicated atherosclerosis" as central fibrous necrosis and calcification or plaque bleeding and surface thrombosis.
CONCLUSIONS: Our results do not support the hypothesis that systemic Cpn, HSV or CMV- infection or evidence of Cpn-, HSV- or CMV-DNA in carotid plaques causes plaque destabilization and cerebral thromboembolism. Plaque infection could only be observed in cases with advanced atherosclerosis.

Entities:  

Mesh:

Year:  2005        PMID: 16184834     DOI: 10.1024/0301-1526.34.3.163

Source DB:  PubMed          Journal:  Vasa        ISSN: 0301-1526            Impact factor:   1.961


  7 in total

Review 1.  Infection and Stroke: an Update on Recent Progress.

Authors:  Eliza C Miller; Mitchell S V Elkind
Journal:  Curr Neurol Neurosci Rep       Date:  2016-01       Impact factor: 5.081

Review 2.  Infection and Atherosclerosis Development.

Authors:  Lee Ann Campbell; Michael E Rosenfeld
Journal:  Arch Med Res       Date:  2015-05-21       Impact factor: 2.235

3.  Composition of calcifications in children with juvenile dermatomyositis: association with chronic cutaneous inflammation.

Authors:  Lauren M Pachman; Arthur Veis; Stuart Stock; Kathy Abbott; Frank Vicari; Pravin Patel; Diana Giczewski; Catherine Webb; Lyudmila Spevak; Adele L Boskey
Journal:  Arthritis Rheum       Date:  2006-10

4.  Association of Cytomegalovirus End-Organ Disease with Stroke in People Living with HIV/AIDS: A Nationwide Population-Based Cohort Study.

Authors:  Yung-Feng Yen; Ian Jen; Marcelo Chen; Pei-Hung Chuang; Yen-Ling Liu; Gerald B Sharp; Yi-Ming Arthur Chen
Journal:  PLoS One       Date:  2016-03-17       Impact factor: 3.240

5.  Evaluation of the relationship between plaque formation leading to symptomatic carotid artery stenosis and cytomegalovirus by investigating the virus DNA.

Authors:  Metin Onur Beyaz; Murat Ugurlucan; Didem Melis Oztas; Mert Meric; Cenk Conkbayir; Ali Agacfidan; Mustafa Onel; Ufuk Alpagut
Journal:  Arch Med Sci Atheroscler Dis       Date:  2019-03-04

6.  Is there any relationship between Chlamydophila pneumoniae and coronary atherosclerosis among Iranians?

Authors:  Mohammad Hadi Sadeghian; Seyed Abbas Tabatabaee Yazdi; Hossein Ayatollahi; Mohammad Reza Keramati; Kiarash Ghazvini; Ali Reza Rezai; Nasrin Heidari; Maryam Sheikhi; Gohar Shaghayegh
Journal:  Niger Med J       Date:  2013-01

Review 7.  Antigen-induced immunomodulation in the pathogenesis of atherosclerosis.

Authors:  Natalia Milioti; Alexandra Bermudez-Fajardo; Manuel L Penichet; Ernesto Oviedo-Orta
Journal:  Clin Dev Immunol       Date:  2008
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.